Dual actions of procainamide on batrachotoxin-activated sodium channels: open channel block and prevention of inactivation - PubMed (original) (raw)

Comparative Study

Dual actions of procainamide on batrachotoxin-activated sodium channels: open channel block and prevention of inactivation

G W Zamponi et al. Biophys J. 1993 Dec.

Erratum in

Biophys J 1994 Mar;66(3 Pt 1):931

Abstract

We have investigated the action of procainamide on batrachotoxin (BTX)-activated sodium channels from bovine heart and rat skeletal muscle. When applied to the intracellular side, procainamide induced rapid, open-channel block. We estimated rate constants using amplitude distribution analysis (Yellen, G. 1984. J. Gen. Physiol. 84:157). Membrane depolarization increased the blocking rate and slowed unblock. The rate constants were similar in both magnitude and voltage dependence for cardiac and skeletal muscle channels. Qualitatively, this block resembled the fast open-channel block by lidocaine (Zamponi, G. W., D. D. Doyle, and R. J. French. 1993. Biophys. J. 65:80), but procainamide was about sevenfold less potent. Molecular modeling suggests that the difference in potency between procainamide and lidocaine might arise from the relative orientation of their aromatic rings, or from differences in the structure of the aryl-amine link. For the cardiac channels, procainamide reduced the frequency of transitions to a long-lived closed state which shows features characteristic of inactivation (Zamponi, G. W., D. D. Doyle, and R. J. French. 1993. Biophys J. 65:91). Mean durations of kinetically identified closed states were not affected. The degree of fast block and of inhibition of the slow closures were correlated. Internally applied QX-314, a lidocaine derivative and also a fast blocker, produced a similar effect. Thus, drug binding to the fast blocking site appears to inhibit inactivation in BTX-activated cardiac channels.

PubMed Disclaimer

Cited by

Pediatric antiarrhythmics and toxicity: A clinical review.
Geanacopoulos AT, Zielonka B, Fox MT, Kerr S, Chambers KD, Przybylski R, Burns MM. Geanacopoulos AT, et al. J Am Coll Emerg Physicians Open. 2024 Feb 15;5(1):e13090. doi: 10.1002/emp2.13090. eCollection 2024 Feb. J Am Coll Emerg Physicians Open. 2024. PMID: 38371660 Free PMC article. Review.
Imidazolium Chloride: An Efficient Catalyst for Transamidation of Primary Amines.
Tian Q, Gan Z, Wang X, Li D, Luo W, Wang H, Dai Z, Yuan J. Tian Q, et al. Molecules. 2018 Sep 2;23(9):2234. doi: 10.3390/molecules23092234. Molecules. 2018. PMID: 30200533 Free PMC article.
Molecular basis for class Ib anti-arrhythmic inhibition of cardiac sodium channels.
Pless SA, Galpin JD, Frankel A, Ahern CA. Pless SA, et al. Nat Commun. 2011 Jun 14;2:351. doi: 10.1038/ncomms1351. Nat Commun. 2011. PMID: 21673672
Potent and use-dependent block of cardiac sodium channels by U-50,488H, a benzeneacetamide kappa opioid receptor agonist.
Pugsley MK, Yu EJ, Goldin AL. Pugsley MK, et al. Exp Clin Cardiol. 2001 Summer;6(2):61-71. Exp Clin Cardiol. 2001. PMID: 20428265 Free PMC article.
Dissecting lidocaine action: diethylamide and phenol mimic separate modes of lidocaine block of sodium channels from heart and skeletal muscle.
Zamponi GW, French RJ. Zamponi GW, et al. Biophys J. 1993 Dec;65(6):2335-47. doi: 10.1016/S0006-3495(93)81292-X. Biophys J. 1993. PMID: 8312473 Free PMC article.

References

1. J Physiol. 1955 Sep 28;129(3):568-82 - PubMed
1. J Mol Cell Cardiol. 1991 Feb;23 Suppl 1:85-93 - PubMed
1. J Med Chem. 1992 May 15;35(10):1806-12 - PubMed
1. Pflugers Arch. 1987 Nov;410(4-5):530-53 - PubMed
1. Naunyn Schmiedebergs Arch Pharmacol. 1979 Nov;309(2):179-90 - PubMed

Dual actions of procainamide on batrachotoxin-activated sodium channels: open channel block and prevention of inactivation - PubMed (original) (raw)